Standard Molecular Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.44M
- Investors
-
1
Standard Molecular General Information
Description
Developer of a purpose-engineered genomic testing system designed to access discrete genomic data. The company's system offers personalized medicine, genetic testing, and cancer genomics and presents distinctive opportunities to clinicians, enabling clinicians in diagnostic and therapeutic innovation to optimize workflow and integrate data with existing information systems in the laboratory and across the health system.
Contact Information
Website
www.standardmolecular.comCorporate Office
- One Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Corporate Office
- One Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Standard Molecular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 09-Apr-2018 | $1.44M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 08-Apr-2016 | Completed | Generating Revenue |
Standard Molecular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Standard Molecular Patents
Standard Molecular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220044810-A1 | Integrated diagnostic test requisition and clinical decision support | Active | 05-Aug-2020 | ||
| US-11798687-B2 | Integrated diagnostic test requisition and clinical decision support | Active | 05-Aug-2020 | ||
| US-20240013922-A1 | Integrated diagnostic test requisition and clinical decision support | Inactive | 05-Aug-2020 | G16H50/20 |
Standard Molecular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Standard Molecular Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Evidity Health Capital | Growth/Expansion | Minority |
Standard Molecular FAQs
-
When was Standard Molecular founded?
Standard Molecular was founded in 2014.
-
Where is Standard Molecular headquartered?
Standard Molecular is headquartered in Cambridge, MA.
-
What is the size of Standard Molecular?
Standard Molecular has 6 total employees.
-
What industry is Standard Molecular in?
Standard Molecular’s primary industry is Biotechnology.
-
Is Standard Molecular a private or public company?
Standard Molecular is a Private company.
-
What is the current valuation of Standard Molecular?
The current valuation of Standard Molecular is .
-
What is Standard Molecular’s current revenue?
The current revenue for Standard Molecular is .
-
How much funding has Standard Molecular raised over time?
Standard Molecular has raised $2.04M.
-
Who are Standard Molecular’s investors?
Evidity Health Capital has invested in Standard Molecular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
